IQVIA (IQV) EBITDA (2012 - 2026)
IQVIA (IQV) EBITDA from Mar 31, 2012 to Mar 31, 2026. The TTM IQVIA (IQV) EBITDA is $3.37B. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
IQVIA (IQV) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +1.81% |
| 3 Years TTM | +5.07% |
| 5 Years TTM | +9.14% |
| 10 Years TTM | +15.29% |
| All Time TTM | +15.47% |
Annual EBITDA change of IQVIA (IQV)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | $802M | -75.89% |
| 2025 | $3.33B | +0.30% |
| 2024 | $3.32B | +6.90% |
| 2023 | $3.10B | +5.91% |
| 2022 | $2.93B | +10.24% |
| 2021 | $2.66B | +31.67% |
| 2020 | $2.02B | +1.97% |
| 2019 | $1.98B | +5.15% |
| 2018 | $1.88B | +12.29% |
| 2017 | $1.68B | +93.76% |
| 2016 | $865M | +11.76% |
| 2015 | $774M | +8.86% |
| 2014 | $711M | +24.77% |
| 2013 | $570M | +15.18% |
| 2012 | $495M | +13.14% |
| 2011 | $437M | N/A |
Comparison IQVIA (IQV) five years EBITDA CAGR with competitors
IQVIA (IQV) five years EBITDA CAGR is 9.14%.
| Ticker | Name | five years EBITDA CAGR | Upside |
|---|---|---|---|
| PRPH | ProPhase Labs Inc | 73.15% | +700.06% |
| MEDP | Medpace Holdings Inc | 25.16% | +175.18% |
| ISPC | iSpecimen Inc | 25.14% | +174.94% |
| PSNL | Personalis Inc | 18.83% | +105.91% |
| WAT | Waters Corp | 17.45% | +90.89% |
| BNR | Burning Rock Biotech Ltd | 17.26% | +88.79% |
| ICLR | Icon Plc | 12.53% | +37.07% |
| IDXX | Idexx Laboratories Inc | 11.66% | +27.56% |
| CSTL | Castle Biosciences Inc | 10.29% | +12.52% |
| MTD | Mettler-Toledo International Inc | 9.87% | +7.92% |
| MYNZ | Mainz Biomed N.V. | 9.82% | +7.40% |
| RDNT | Radnet Inc | 8.38% | -8.29% |
| IMDX | Insight Molecular Diagnostics Inc | 7.62% | -16.71% |
| A | Agilent Technologies Inc | 6.59% | -27.94% |
| ILMN | Illumina Inc | 5.98% | -34.57% |
| GH | Guardant Health Inc | 5.67% | -37.98% |
| NTRA | Natera Inc | 3.35% | -63.35% |
| TWST | Twist Bioscience Corp | 2.84% | -68.95% |
| BDSX | Biodesix Inc | 2.43% | -73.38% |
| SHC | Sotera Health Company | 2.32% | -74.61% |
| QGEN | Qiagen NV | 2.21% | -75.88% |